Literature DB >> 7184937

Combined hemoperfusion-hemodialysis in organophosphate poisoning.

J Nagler, R A Braeckman, J L Willems, G A Verpooten, M E De Broe.   

Abstract

We report on a patient treated with combined prolonged hemoperfusion (HP, Adsorba 300 C, Gambro, Sweden) and hemodialysis (HD, C-DAK 1.2, Cordis Dow, USA) for severe dimethoate poisoning. This procedure was adopted since the combination of dialysis and adsorption may improve overall drug removal. Combined HP-HD was performed during 24 h using the same charcoal column and dialyser. Adequate heparinization was obtained by monitoring the whole blood activated partial thromboplastin time. The patient (a 34-year-old female) ingested approximately 10 g of dimethoate (Teletox 10) in a suicide attempt, 30 min before admission to the hospital. On admission, serum level of dimethoate (analysed by gas chromatography) was 2340 ng ml-1. She received conventional treatment and combined HP-HD was started within 2 h after admission. At this time serum levels had risen to 3110 ng ml-1. However, they declined constantly during the epuration and after 18 h no more dimethoate could be detected in the serum. She was discharged 3 days after treatment. During the 24 h of HP-HD treatment, 110.8 mg dimethoate entered the epuration system via the plasma. 55.3 mg were extracted by the charcoal column and 25.3 mg by hemodialysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7184937     DOI: 10.1002/jat.2550010403

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  3 in total

1.  Hemoperfusion in severe dimethoate poisoning.

Authors:  C Köppel; Z Forycki; K Ibe
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

2.  Utilization of plasmapheresis for organophosphate intoxication: A case report.

Authors:  Nezihat Rana Disel; Ayca Acikalin; Zeynep Kekec; Ahmet Sebe
Journal:  Turk J Emerg Med       Date:  2016-05-07

3.  Combined hemoperfusion and hemodialysis treatment of poisoning with cholinesterase inhibitors.

Authors:  Z Durakovic
Journal:  Korean J Intern Med       Date:  1993-07       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.